Annalisa Pastore Selected Research

Friedreich Ataxia (Friedreich's Ataxia)

12/2019	A new tool to determine the cellular metabolic landscape: nanotechnology to the study of Friedreich's ataxia.
1/2019	Characterization of human frataxin missense variants in cancer tissues.
1/2019	Structural and functional characterization of a frataxin from a thermophilic organism.
1/2018	Chemical shift assignment of a thermophile frataxin.
1/2018	Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell model.
1/2017	New Techniques for Ancient Proteins: Direct Coupling Analysis Applied on Proteins Involved in Iron Sulfur Cluster Biogenesis.
7/2015	A new cellular model to follow Friedreich's ataxia development in a time-resolved way.
1/2015	Analyzing the Effects of a G137V Mutation in the FXN Gene.
4/2014	The kinetics of folding of frataxin.
1/2014	Yeast frataxin is stabilized by low salt concentrations: cold denaturation disentangles ionic strength effects from specific interactions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annalisa Pastore Research Topics

Disease

36	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2002
23	Friedreich Ataxia (Friedreich's Ataxia) 12/2019 - 06/2004
13	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2015 - 05/2005
10	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2021 - 08/2003
10	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 02/2003
7	Fragile X Syndrome (Martin Bell Syndrome) 04/2009 - 03/2003
4	Huntington Disease (Huntington's Disease) 01/2019 - 12/2008
4	Intellectual Disability (Idiocy) 06/2010 - 10/2003
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 12/2020
3	Neoplasms (Cancer) 01/2019 - 01/2013
3	Hemorrhage 01/2018 - 03/2011
3	Ataxia (Dyssynergia) 01/2017 - 01/2011
3	MYH9-Related Disorders 01/2013 - 12/2009
2	Thrombocytopenia (Thrombopenia) 01/2022 - 02/2014
2	Carcinogenesis 01/2019 - 10/2014
2	Infections 01/2018 - 05/2012
2	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 09/2014 - 03/2011
2	Proteostasis Deficiencies 01/2013 - 06/2008
1	Frontotemporal Dementia (Semantic Dementia) 01/2022
1	TDP-43 Proteinopathies 12/2019
1	Bacterial Infections (Bacterial Infection) 12/2018
1	Tuberculosis (Tuberculoses) 01/2018
1	Congenital amegakaryocytic thrombocytopenia 01/2018
1	Bone Marrow Failure Disorders 01/2018
1	Stroke (Strokes) 10/2016
1	Pancreatitis 10/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Type 2 Diabetes Mellitus (MODY) 05/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2014
1	Iron Overload 08/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2013
1	X-Linked Mental Retardation (Mental Retardation, X Linked) 04/2012
1	Meningitis 12/2011
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 10/2011
1	Neuroblastoma 10/2011
1	Renpenning syndrome 1 06/2010
1	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 04/2010
1	Paraplegia (Spastic Paraplegia) 04/2010
1	familial dilated cardiomyopathy 04/2004
1	Brain Diseases (Brain Disorder) 02/2003
1	Cystic Fibrosis (Mucoviscidosis) 02/2003

Drug/Important Bio-Agent (IBA)

41	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
24	FrataxinIBA 12/2019 - 06/2004
21	polyglutamineIBA 01/2021 - 02/2002
14	Ataxin-3IBA 01/2021 - 08/2003
10	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2018 - 08/2004
9	Ataxin-1IBA 10/2014 - 05/2005
7	IronIBA 01/2019 - 09/2006
6	UbiquitinIBA 01/2021 - 12/2006
6	Peptides (Polypeptides)IBA 01/2020 - 02/2003
4	SulfurIBA 01/2019 - 08/2013
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2015 - 12/2006
4	Fragile X Mental Retardation ProteinIBA 04/2009 - 10/2003
3	PrionsIBA 12/2020 - 02/2003
3	RNA (Ribonucleic Acid)IBA 12/2020 - 03/2003
3	Amyloid (Amyloid Fibrils)IBA 01/2018 - 06/2008
3	Cysteine Proteases (Cysteine Protease)IBA 01/2015 - 12/2009
3	Amyloid beta-PeptidesIBA 10/2013 - 06/2008
3	Nonmuscle Myosin Type IIAIBA 01/2013 - 12/2009
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2006 - 07/2003
2	von Willebrand FactorIBA 09/2014 - 03/2011
2	Pharmaceutical PreparationsIBA 01/2013 - 01/2013
2	VaccinesIBA 12/2011 - 08/2002
2	Prion ProteinsIBA 10/2011 - 07/2010
1	EnzymesIBA 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	Huntingtin ProteinIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2018
1	Thrombopoietin (c-mpl Ligand)IBA 01/2018
1	4,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA 01/2018
1	Free RadicalsIBA 01/2018
1	romiplostim FDA Link 01/2018
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2016
1	Histidine (L-Histidine)FDA Link 02/2016
1	Glutamine (L-Glutamine)FDA Link 05/2014
1	Arginine (L-Arginine)FDA Link 05/2014
1	Protein Isoforms (Isoforms)IBA 02/2014
1	Cytochromes c (Cytochrome c)IBA 02/2014
1	MetalsIBA 01/2014
1	Carrier Proteins (Binding Protein)IBA 01/2014
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2013
1	Deubiquitinating EnzymesIBA 01/2013
1	SteroidsIBA 05/2012
1	Sulfates (Sulfates, Inorganic)IBA 05/2012
1	Serine (L-Serine)FDA Link 01/2012
1	AntigensIBA 12/2011
1	Endopeptidase K (Proteinase K)IBA 10/2011
1	poly-d-lysineIBA 10/2011
1	Biological ProductsIBA 09/2011
1	RNA Precursors (Precursor, mRNA)IBA 06/2010
1	ProteomeIBA 04/2010
1	Peptide Hydrolases (Proteases)FDA Link 04/2010
1	Metalloproteases (Metalloproteinases)IBA 04/2010
1	MetallochaperonesIBA 07/2008
1	alpha-SynucleinIBA 06/2008
1	Codon (Codons)IBA 12/2006
1	AsparagineIBA 03/2003

Therapy/Procedure

1	Therapeutics 01/2018
1	Hematopoietic Stem Cell Transplantation 01/2018